CDD

Publishings Digital Health

  • News

    A Big Win for Commercial Surveillance on the Internet -- a Gigantic Loss for Democracy

    US Citizens and Consumers left further exposed to unfair and discriminatory data practices.

    The following can be attributed to Katharina Kopp, Policy Director, Center for Digital Democracy. --- Today’s House vote to overturn the first major Internet privacy protection for Americans, may be a win for ISP monopolies, but it’s a tragic loss for our democracy. Broadband providers, such as AT&T, Comcast and Verizon, will now be able to sell our sensitive information to the highest bidder without first receiving our permission. We believe today’s misguided vote will unleash even more “Big Data” profiling and tracking of Americans, and spur an array of discriminatory practices. Without any restraints, ISPs will dramatically erode what should be an important American fundamental right—that of privacy. If President Trump allows this bill to become law, his Administration will place new burdens on hard-working Americans and their families—who will be at the mercy of a handful of digital giants. CDD and our allies, here and in the EU, pledge to continue our fight against the special interests that have gained new ways to control how we use the Internet and other digital media. Contact: Jeff Chester Executive Director Center for Digital Democracy Washington, DC. www. democraticmedia.org jeff@democraticmedia.org (link sends e-mail) 202-494-7100
  • CDD Executive Director, Jeff Chester speaks on Congress’ dismantling of the FCC Privacy Rule with CNN’s Jake Tapper on March 29th, 2017. Full interview available at http://www.edition.cnn.com/videos/tv/2017/03/29/internet-privacy-rules-c... (link is external).
  • Reports

    The New Age of Food Marketing

    How companies are targeting and luring our kids — and what advocates can do about it

    This report provides a snapshot of five categories of marketing tactics used by fast food, snack food, and soft drink companies to target children and adolescents. These categories include: 1) creating immersive environments; 2) infiltrating social networks; 3) location-based and mobile marketing; 4) collecting personal data; and 5) studying and triggering the subconscious. Descriptions of these categories along with examples from the food and beverage industry are provided. The report concludes with a discussion of what advocates can do to protect children and adolescents from these harmful marketing tactics.
  • Youth of color are a key focus for digital marketers, especially for fast-foods and beverages linked to the youth obesity epidemic.  The digital targeting of African American and Hispanic youth is growing, and uses a full array of sophisticated mobile, geo-location, social media and other cutting-edge marketing strategies.  Food and beverage marketers should adopt practices that stop unfair and irresponsible digital marketing practices.  The FTC and State AG's should call for safeguards.Here's the latest CDD Infographic that addresses African American youth.
  • A personal essay in the New York Review of Books (link is external) by Dr. Arnold Relman on his recent serious accident reminds us that not only does fate play an important role in our lives, but the limits of our health care system. I urge you to read it. But in addition to the horrific experience he (and his family) had to undergo (and he's a lucky one). Dr. Relman's piece also underscores that the very much-hyped use of technology in health care (such as electronic patient records) brings its own set of contradictions and problems. He writes:But what I hadn’t appreciated was the extent to which, when there is no emergency, new technologies and electronic record-keeping affect how doctors do their work. Attention to the masses of data generated by laboratory and imaging studies has shifted their focus away from the patient. Doctors now spend more time with their computers than at the bedside. That seemed true at both the ICU and Spaulding. Reading the physicians’ notes in the MGH and Spaulding records, I found only a few brief descriptions of how I felt or looked, but there were copious reports of the data from tests and monitoring devices. Conversations with my physicians were infrequent, brief, and hardly ever reported.
  • This letter was sent today to new FTC Chairwoman Edith Ramirez by three-dozen NGOs--including the national leaders in the consumer and privacy fields.
  • CDD, U.S. PIRG, Consumer Watchdog, and World Privacy Forum call on the Federal Trade Commission to investigate interactive marketing of pharmaceutical and health products and services to consumers and health professionals. Action is required to protect consumers, including their privacy, in the online health and medical marketplace. The FTC has a role to play to help the Food and Drug Administration address new threats. Read the press release below for details…
  • For the past 25 years, pharmaceutical companies have been permitted to market their products directly to consumers. More recently, in the years following the Food and Drug Administration’s relaxation of direct-to-consumer (DTC) advertising guidelines in 1997, spending on such promotion grew more than six-fold, reaching $5 billion by 2008. In the traditional media of print and broadcast, those DTC ads come with lots of fine print, including warnings of possible side effects that most consumers. But now that ever-increasing amounts of pharmaceutical marketing have moved online, there is another kind of fine print—the truth about invasive and potentially misleading pharmaceutical advertising—that consumers may never see at all. The Center for Digital Democracy recently shared these concerns in a formal filing to the FDA, the highlights of which follow: 1. Personal Data Collection and Privacy Online pharmaceutical and health marketing companies have developed an extensive data collection and interactive targeting apparatus. Few U.S. health consumers are aware that they are being identified, labeled, profiled, and tracked on the Internet while they search or access information on specific conditions or concerns. 2. “Condition” and Behavioral Targeted Advertising Behavioral targeting enables health marketers to stealthily follow consumers online—sometimes across many different websites—gathering details on their interests and activities, and then offering them marketing messages precisely honed to their behaviors related to an illness or condition. Digital marketers employ online “ad networks” to help track and then target individual consumers seeking health-related information. There are also a number of specialized health portals and networks specifically created to target consumers based on particular conditions or concerns. 3. Neuromarketing It should perhaps come as no surprise that many of the companies whose products are rooted in scientific research have turned to neuroscientific techniques in an effort to influence health consumers’ subconscious decision-making processes. Called “neuromarketing,” such techniques are increasingly employed to research, design, and implement online advertising campaigns—including those for health and medical products. NeuroFocus, for example, a firm that specializes in the application of brainwave research to advertising, programming, and messaging, uses “neurological testing [that] delves down to the subconscious mind,” far below such “corrupting factors” as education, language, and cultural variances. Measuring as many as 64-128 sectors of the brain at 2,000 times per second, NeuroFocus promises results that are “unambiguous, accurate, and actionable”—results, we should add, that are achieved without the consumer’s knowledge or consent. 4. Social Media Monitoring and Marketing Perhaps most alarmingly, marketers have developed applications that allow companies to eavesdrop and analyze conversations by and among health consumers, taking advantage of users’ networks of friends to orchestrate peer-to-peer brand promotion. These new surveillance tools monitor conversations among social network users to identify what is being said about a particular issue or product. Marketers then work to insert brand-related messages into the social dialogue, often by identifying and targeting individuals considered brand “loyalists” or “influencers,” and encouraging them to generate buzz through their networks of friends. Increasingly, advertisers are using Facebook’s marketing apparatus—which is largely invisible to its users—to develop a brand presence on its pages so companies can strongly connect to the social communications of a very large pool of consumers. Heartbeat Digital’s BuzzScape, for example “allows clients to monitor discussions that flow in and out of the tens of thousands of message boards, forums, blogs and social networks that increasingly dominate the online environment.” As Heartbeat CEO Bill Drummy admits, “In a sense, we eavesdrop on public conversations among people with a shared interest, then use what we learn to create interactive marketing campaigns that address the identified needs, wants and gaps in knowledge of target audiences.” Perhaps the biggest gap in audience knowledge, of course, is awareness of the fact that online conversations concerning the most sensitive health concerns have become just so much grist for the pharmaceutical marketing mills. 5. Unbranded Sites Another common practice among pharmaceutical companies is the use of online video and websites to raise the awareness of a particular disease or condition—often without clear disclosure of sponsor relationships. Ostensibly designed as educational sites, where individuals can share their experiences with various treatments for certain maladies, sites such as LivingWithEpilepsy.com or ParkinsonsHealth.com are also useful to pharmaceutical companies as a “soft sell” opportunity, free of FDA-mandated risk-disclosure and other advertising requirements. 6. Ad Exchanges These commercial arrangements allow companies to auction off individual users to specific advertisers in real time for ad targeting. Increasingly, the targeting is accompanied by so-called “data optimization,” which draws on various information resources to compile more complete profiles of individual users. For example, Google/DoubleClick’s Ad Exchange Health focus has 36 categories, from Arthritis and Diabetes to Respiratory Conditions and Sleep Disorders. Another advertising network, ADSDAQ, offers 50 health-related categories, from A.D.D. and Alzheimer’s Disease to Weight Loss and Women’s Health. Again, consumers are never apprised of the way their personal data—including intimate health-related information—is being sold to the highest bidder. 7. Audience Segmentation The division of consumers into much smaller affinity groups (e.g., Business Travelers, Sports Fans, Technophiles) for the purpose of targeted marketing is a longstanding advertising practice. Its use by pharmaceutical marketers, however, especially in the digital context, raises a number of critical issues. The segments into which pharmaceutical companies divide their audiences go far beyond demographic and lifestyle categories to include highly personal and sensitive information relating to one’s health. For example, as Mark Miller, senior vice president for healthcare marketer Epsilon, explains, “Segment profiling dimensions include (but are not limited to): market size, geo-demographic characteristics, medication usage, self-care behaviors, bio-metrics, insurance coverage/ usage, needs/attitudes/behaviors and media consumption.” The goal of these data collection and analysis efforts, moreover, is to influence consumer behavior in some of the most personal and profound decisions they will ever have to make, concerning their own and their family’s health. 8. Mobile Campaigns Many of the same consumer data collection, profiling, and behavioral targeting techniques that have raised concerns in the more “traditional” online world have now been brought into the mobile phone marketplace. As U.S. consumers increasingly rely on their mobile devices for a wide range of services, including sensitive transactions related to health, the expansion of behavioral targeting into the mobile world (where it will be combined with precise user and location data) is especially troubling. “Not only does Mobile have a ubiquitous presence—with us 24/7,” boasts Peter Nalen, CEO of Compass Healthcare Communications, “—it can also reach more people, more efficiently, and with greater targetability.” That’s not the kind of personalized service, however, that consumers may want or need in the healthcare arena. And that’s why CDD has called upon the FDA to remedy this situation, first by conducting a comprehensive investigation into the use and impact of digital-health marketing techniques and technologies, and then by working with the Federal Trade Commission and other appropriate agencies to develop a set of policies for regulating the use of behavioral targeting, data collection, and other digital techniques in the marketing of drugs and health-related products.